Cancer Genetics, Inc.

Construction Equipment and Supplies

Complete::IO analyzes dynamic changes across immune cells.

Used in monitoring patients immunity and assessment of potential toxicities of IO in blood cancer snd solid tumors, Complete::IO™ Flow Cytometry Panel provides immunophenotyping of central memory, effector, effector memory, naïve CD4+ and CD8+ T cells, T-regs, B-regs, NK, and plasmacytoid dendritic cells. Offering streamlined specimen setup and reporting 24 hrs reporting turnaround time....

Read More »
People in the News

Cancer Genetics, Inc. Chief Executive Officer Steps Down

Board Appoints COO, Jay Roberts, Interim Chief Executive Officer RUTHERFORD, N.J., Feb. 05, 2018 - Cancer Genetics, Inc. (Nasdaq:CGIX) an emerging leader in enabling precision medicine for oncology through the use of molecular markers and information, announced today that Panna Sharma will be stepping down as President, Chief Executive Officer and a director of the Company. The Company’s Board...

Read More »
Construction Equipment and Supplies

Complete::IO analyzes dynamic changes across immune cells.

Used in monitoring patients immunity and assessment of potential toxicities of IO in blood cancer snd solid tumors, Complete::IO™ Flow Cytometry Panel provides immunophenotyping of central memory, effector, effector memory, naïve CD4+ and CD8+ T cells, T-regs, B-regs, NK, and plasmacytoid dendritic cells. Offering streamlined specimen setup and reporting 24 hrs reporting turnaround time....

Read More »

All Topics